Ah ya think ? They’re not even submitting it to the FDA until either July August or September Q3 at earliest. If it gets submitted in that timeframe look for another six months for FDA to review the data. If approved maybe launch April 2021
If the data was clear, there wouldn’t be this much delay. COVID is an excuse. Do you really think it’s execs and VPs filling out the text and building out the data & charts?
Exactly the data is garbage. This drug is never going to get approved...and if it did payers aren't going to pay for this. It just doesn't work. Good pump for the stock up until today though!